Vincent J. Burgess - 29 Mar 2023 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Director
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
29 Mar 2023
Net transactions value
+$21,578
Form type
4
Filing time
31 Mar 2023, 16:32:14 UTC
Previous filing
02 Jun 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Options Exercise $21,578 +4,860 +155% $4.44 7,995 29 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Options Exercise $0 -4,860 -100% $0.000000* 0 29 Mar 2023 Common Stock 4,860 $4.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.